Angiotensin-Receptor Blockers in Heart Failure: Evidence From the CHARM Trial.

Cleveland Clinic Journal of Medicine - United States
doi 10.3949/ccjm.71.8.665
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Cleveland Clinic Journal of Medicine

Related search

Angiotensin Receptor Blockers (ARBs)

CMAJ
Medicine
2011English

Effect of the Angiotensin Receptor Blocker Valsartan on Morbidity and Mortality in Heart Failure: The Valsartan Heart Failure Trial (Val-HeFT)

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Heart Failure With Chronic Kidney Disease ― Propensity Score Matching Analysis ―

Circulation Journal
MedicineCardiovascular MedicineCardiology
2019English

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

Β Blockers for Heart Failure

British Medical Journal
Medicine
2016English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

Beta-Blockers for Heart Failure

Cochrane Database of Systematic Reviews
2016English

Beta-Blockers for Heart Failure

2000English

The Effect of Angiotensin II Receptor Blockers on Hyperuricemia

Therapeutic Advances in Chronic Disease
Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy